期刊文献+

人工关节置换术围手术期的血液管理策略 被引量:16

PERIOPERATIVE BLOOD MANAGEMENT STRATEGIES FOR JOINT ARTHROPLASTY
原文传递
导出
摘要 目的综述人工关节置换术围手术期血液管理策略。方法查阅近年国内外相关文献,对人工关节置换术前、术中及术后血液管理相关研究进行总结分析。结果目前人工关节置换围手术期血液管理方式较多,其中术前包括补充铁剂、使用促红细胞生成素和自体血储备,术中包括急性等容血液稀释技术、抗纤溶治疗、使用止血带等,术后包括使用自体血回输系统以及严格的输血指征。对贫血患者,术前单独使用促红细胞生成素或者联合自体血储备可以降低术后输血率,术中使用止血带及静脉输注氨甲环酸也能有效控制术中出血,术后采取严格的输血指征可有效减少不必要的输血。结论人工关节置换术围手术期血液管理应针对患者个体情况综合使用多种方式,减少围手术期失血及输血,促进患者康复。 Objective To summarize the perioperative blood management strategies for joint arthroplasty. Methods The literature concerning preoperative, intraoperative, and postoperative blood management was reviewed and summarized. Results At present, a variety of blood management and conservation strategies are available. Preoperative strategies include iron supplementation, erythropoietin (EPO), and preoperative autologous donation (PAD). Intraoperative options include acute normovolemic hemodilution (ANH), antifibrinolytics, and the use of a tourniquet. Postoperative strategies include the use of reinfusion systems and guided transfusion protocols. Preoperatively, administration of either simple EPO or a combination of EPO and PAD can be efficacious in anemic patients. Intraoperatively, tourniquet use and tranexamic acid can effectively control bleeding. Postoperatively, appropriate transfusion indications can avoid unnecessary blood transfusions. Conclusion Perioperative blood management strategies for joint arthroplasty should be integrated for the individual patient using a variety of ways to reduce perioperative blood loss and blood transfusion, and promote the rehabilitation of patients.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2015年第6期772-776,共5页 Chinese Journal of Reparative and Reconstructive Surgery
关键词 人工关节置换术 围手术期 失血 输血 Arthroplasty Perioperative period Blood loss Blood transfusion
  • 相关文献

参考文献44

  • 1Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion, 2003, 43(4): 459-469.
  • 2Stulberg BN, Zadzilka JD. Blood management issues using blood management strategies. J Arthroplasty, 2007, 22(4 Suppl 1): 95-98.
  • 3Hart A, Khalil JA, Carli A, et al. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. JBone Joint Surg (Am), 2014, 96(23): 1945-1951.
  • 4Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology, 2010, 113(2): 482-495.
  • 5Carson IL, Noveck H, Berlin JA, et al. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion, 2002, 42(7): 812-818.
  • 6Kapadia BH, Banerjee S, Issa K, et al. Preoperative blood management strategies for total knee arthroplasty. J Knee Surg, 2013, 26(6): 373-377.
  • 7Andrews CM, Lane DW, Bradley IG. Iron pre-load for major joint replacement. Transfus Med, 1997, 7(4): 281-286.
  • 8Lachance K, Savoie M, Bernard M, et al. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother, 2011, 45(6): 764-770.
  • 9lelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev, 1992, 72(2): 449-489.
  • 10So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology, 2014, 120(4): 839-851.

共引文献12

同被引文献152

  • 1王武炼,林丽琼,沈富儿,冯尔宥,肖莉莉,张怡元.自体血回输在复杂人工全髋关节置换术围手术期的应用[J].福建中医药大学学报,2013,23(2):15-16. 被引量:2
  • 2颜德馨,胡泉林,王平平,周晓燕,宓哲伟,周良彦.气虚血瘀是人体衰老的主要机制[J].中国医药学报,1989,4(2):10-12. 被引量:113
  • 3Bozic KJ,Kurtz SM,Lau E,et al.The epidemiology of revisiontotal hip arthroplasty in the United States[J].J Bone Joint Surg Am,2009,9(1):128-133.
  • 4Cherian JJ,Kapadia BH,Issa K,et al.Preoperative BloodManagement Strategies for Total Hip Arthroplasty[J].Surg Technol Int,2013,9(30):23-37.
  • 5Conlon NP,Bale EP,Herbison GP,et al.Postoperative anemia and quality of life after primary hip arthroplasty in patients over 65 years old[J].Anesth Analg,2008,106(4):1056-1061.
  • 6Nichols CI,Vose JG.Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral,bilateral,and revision total knee arthroplasty procedures[J].J Arthroplasty,2016,31(3):583-589.
  • 7Bou Monsef J,Boettner F.Blood management may have an impact on length of stay after total hip arthroplasty[J].HSSJ,2014,10(2):124-130.
  • 8Woo da E,Lee JM,Kim YK,et al.Recombinant human erythropoietin therapy for a Jehovah's witness child with severe anemia due to hemolytic-uremic syndrome[J].Korean J Pediatr,2016,59(2):100-103.
  • 9de Araújo Loures E,Leite IC.Analysis on quality of life of patients with osteoarthrosis undergoing total hip arthroplasty[J].Rev Bras Ortop,2015,47(4):498-504.
  • 10Berry DJ,Harmsen WS,Cabanela ME,et al.Twenty-fiveyear survivorship of two thousand consecutive primary Charnley total hip replacements:factors affecting survivorship of acetabular and femoral components[J].J Bone Joint Surg Am,2002,84-A(2):171-176.

引证文献16

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部